General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vandrey R et al. - Results from controlled laboratory studies and small open-label clinical studies indicate that buspirone, dronabinol, fluoxetine, lithium and lofexidine may have therapeutic benefit for those seeking treatment for cannabis-related problems. However, controlled clinical trials have not been conducted and are needed to both confirm the potential clinical efficacy of these medications and to validate the laboratory models being used to study candidate medications.

Related Articles

New UK study suggests minimal relationship between cannabis and schizophrenia or psychosis
EurekAlert, 10/23/09    Relevance Score: 91%

If cannabis caused schizophrenia how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations
Addiction, 10/19/09    Relevance Score: 91%

Adverse health effects of non-medical cannabis use
The Lancet, 10/19/09    Relevance Score: 88%

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
Schizophrenia Bulletin, 11/16/09    Relevance Score: 87%

Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study
Journal of the American Academy of Child and Adolescent Psychiatry, 10/29/09    Relevance Score: 87%

Today in Mental Health...keeping you current

Anorexia Nervosa
FOCUS (The Journal of Lifelong Learning in Psychiatry), 12/09/09

Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Therapeutics and Clinical Risk Management, 12/09/09

The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis
International Journal of Obesity, 12/09/09

Today in Substance Abuse...keeping you current

Psychophysiological disorders among buprenorphine patients
International Journal of Psychiatry in Clinical Practice, 12/09/09

High-potency cannabis and the risk of psychosis
British Journal of Psychiatry, 12/09/09

A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence
Journal of Psychopharmacology, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address